Luca Stocchi MD,MBA

158 posts

Luca Stocchi MD,MBA banner
Luca Stocchi MD,MBA

Luca Stocchi MD,MBA

@LucaStocchiMD

Chair, Division of #ColorectalSurgery at @MayoClinic. #IBD expert. Tweets = mine. #MayoClinicFL

Jacksonville, FL Katılım Eylül 2017
64 Takip Edilen766 Takipçiler
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Great work to organize our yearly course thanks to Jana Al Hashash Jami Kinnucan Frank Farraye Mike Picco
Luca Stocchi MD,MBA tweet media
English
0
2
18
781
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Mayo Clinic Florida IBD course. Lots of information for gastroenterologists but also useful for surgeons
Luca Stocchi MD,MBA tweet media
English
0
1
10
188
Luca Stocchi MD,MBA retweetledi
Sean Langenfeld
Sean Langenfeld@SeanLangenfeld·
Interesting @SurgEndosc study from @MSKCancerCenter looking at patterns and detection of local regrowth in patients with rectal cancer who experience cCR after TNT and undergo watch-and-wait (2006-2020) -Suspected local regrowth occurred in 30% -Abnormal MRI with normal endoscopy was uncommon (11% of suspected regrowths) compared to Normal MRI/abnormal endoscopy (32%) and abnormalities on both MRI and endoscopy (57%) -For patients undergoing salvage surgery, the rate of pCR was 44% in the +MRI/-Endo group, 18% for the -MRI/+Endo group, and 4% for the +MRI/+Endo group. This means residual/recurrent cancer was much more likely to be present in the final specimen if the endoscopy was abnormal. -Of the 99 patients with salvage surgery and recurrent cancer on final pathology, only 1 patient (1%) had this recurrence detected by MRI alone. Important caveats: -This study goes back to 2006, and MRIs have certainly evolved during that time (as have TNT, surveillance, etc). -All false positive MRI findings occurred after 2013, suggesting newer MRIs pick up subtle abnormalities that aren't necessarily cancer regrowth. -pCR on final pathology shouldn't necessarily be considered a failure in management. These patients do very well. What I take home from this study is that isolated irregularities on surveillance MRI can be safely monitored without proctectomy in the short-term...ie you can leave the rectum in for a little while and let the problem declare itself. pubmed.ncbi.nlm.nih.gov/40659952/
Sean Langenfeld tweet media
English
4
19
44
3.8K
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Nancy You at our Grand Rounds presenting on young onset colorectal cancer
Luca Stocchi MD,MBA tweet media
English
0
0
9
812
Luca Stocchi MD,MBA retweetledi
James Jakub
James Jakub@DrJamesJakub·
What I heard at Grand Rounds @tsikitis -4 subtypes of CRC. Early onset CRC is not a unique subtype -TME Immune profiling different for EOCRC -early exposures + diet + microbiome + immunity/imflammation/obesity=EOCRC -normal mucosa, NOT fecal microbiome predicts adenoma formers
James Jakub tweet mediaJames Jakub tweet mediaJames Jakub tweet mediaJames Jakub tweet media
English
0
8
30
1.9K
Luca Stocchi MD,MBA retweetledi
Sean Langenfeld
Sean Langenfeld@SeanLangenfeld·
This is the most important study you'll see on twitter today. I'm swamped with other work, but I had to read it. Fascinating @NEJM article from @MSKCancerCenter with Longer-term data (and more patients): 6 months of single-agent immunotherapy for MMR-deficient rectal cancers, which as we all know rocked the world in 2022 with the first 12 reported patients (100% cCR). They now have 49 patients with dMMR rectal cancer (50% sporadic, 50% Lynch). All 49 developed a cCR, and 47/49 (96%) had a sustained cCR at a median f/u of 30 months. Both recurrences went back on immunotherapy and did not receive proctectomy. The study's second cohort is exploratory and has shorter f/u, but it does appear that the future of dMMR colon cancer could be non-operative as well. So exciting! @ASCRS_1 @AmericanCancer @AmCollSurgeons @coloncancertask #Coloncancer #RectalCancer #Lynch
Andrea Cercek@AndreaCercek

Congratulations to our team. Next chapter in Nonoperative Management of Mismatch Repair–Deficient Tumors | New England Journal of Medicine nejm.org/doi/10.1056/NE…

English
1
7
19
2.7K
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Our research Dean Alfredo Quinones presenting at the Mayo Clinic Advanced Surgical Technologies and Robotics 2025 meeting
Luca Stocchi MD,MBA tweet media
English
2
0
19
646
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Dave Larson presenting on sigmoid diverticulitis at the Mayo Clinic Advanced Surgical Technologies and Robotics 2025 meeting
Luca Stocchi MD,MBA tweet media
English
3
4
28
1.5K
Luca Stocchi MD,MBA retweetledi
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Wobbly chair from IKEA? Our book can help -buy it!
Luca Stocchi MD,MBA tweet media
English
1
1
12
736
Luca Stocchi MD,MBA retweetledi
Richard Brady (researchactive.bsky.social)
📣just out, new paper - mdpi-res.com/d_attachment/n… This reports impact of having a stoma within the 1st year, 43% experience stoma leakage in the preceding 2 weeks & 85% had parastomal skin complications. Strong linkage of leak to Quality of Life & mental health well being.
Richard Brady (researchactive.bsky.social) tweet media
English
4
4
19
1.7K
Luca Stocchi MD,MBA
Luca Stocchi MD,MBA@LucaStocchiMD·
Textbook from the Society of Pelvic Surgeons - gynecologists urologists colorectal surgeons present on morbidity of their operations
English
0
0
1
152